← Tutti eurodeputati

Sven Giegold

Parlamento europeo · 🇩🇪 Germania · ex eurodeputato

Mandato:dal 18 luglio 2019 a 15 dicembre 2021

Partecipazione alle votazioni per appello nominale

97 % del 623 votazioni per appello nominale svoltesi durante il mandato: ha preso parte al voto (a favore, contro o astenuto)

Partecipazione mese per mese

0 % 50 % 100 % luglio 2019 : partecipazione 100 % (1 / 1), presenza 100 % (1 / 1) 2019 settembre 2019 : partecipazione 100 % (5 / 5), presenza 100 % (5 / 5) ottobre 2019 : partecipazione 100 % (19 / 19), presenza 100 % (19 / 19) novembre 2019 : partecipazione 100 % (18 / 18), presenza 100 % (18 / 18) dicembre 2019 : partecipazione 100 % (6 / 6), presenza 100 % (6 / 6) gennaio 2020 : partecipazione 100 % (12 / 12), presenza 100 % (12 / 12) 2020 febbraio 2020 : partecipazione 88 % (7 / 8), presenza 88 % (7 / 8) maggio 2020 : partecipazione 100 % (54 / 54), presenza 100 % (54 / 54) giugno 2020 : partecipazione 100 % (12 / 12), presenza 100 % (12 / 12) luglio 2020 : partecipazione 100 % (19 / 19), presenza 100 % (19 / 19) settembre 2020 : partecipazione 100 % (24 / 24), presenza 100 % (24 / 24) ottobre 2020 : partecipazione 100 % (37 / 37), presenza 100 % (37 / 37) novembre 2020 : partecipazione 100 % (32 / 32), presenza 100 % (32 / 32) dicembre 2020 : partecipazione 100 % (30 / 30), presenza 100 % (30 / 30) gennaio 2021 : partecipazione 100 % (23 / 23), presenza 100 % (23 / 23) 2021 febbraio 2021 : partecipazione 100 % (21 / 21), presenza 100 % (21 / 21) marzo 2021 : partecipazione 100 % (31 / 31), presenza 100 % (31 / 31) aprile 2021 : partecipazione 100 % (81 / 81), presenza 100 % (81 / 81) maggio 2021 : partecipazione 100 % (26 / 26), presenza 100 % (26 / 26) giugno 2021 : partecipazione 97 % (28 / 29), presenza 97 % (28 / 29) luglio 2021 : partecipazione 100 % (27 / 27), presenza 100 % (27 / 27) settembre 2021 : partecipazione 100 % (19 / 19), presenza 100 % (19 / 19) ottobre 2021 : partecipazione 100 % (42 / 42), presenza 100 % (42 / 42) novembre 2021 : partecipazione 70 % (19 / 27), presenza 70 % (19 / 27) dicembre 2021 : partecipazione 60 % (12 / 20), presenza 60 % (12 / 20)

I loro voti

623 votazioni

DataTestoEsitoIl loro voto
The draft Commission regulation amending the Annex to Regulation (EU) No 231/2012 laying down specifications for food additives listed in Annexes II and III to Regulation (EC) No 1333/2008 as regards specifications for titanium dioxide (E 171) A favore
Equivalence of field inspections carried out on cereal seed-producing crops and equivalence of cereal seed produced in Ukraine A favore
European Climate Law A favore
Implementation of the common commercial policy – annual report 2018 A favore
The Establishment of an EU Mechanism on Democracy, the Rule of Law and Fundamental Rights A favore
The European Year of Greener Cities 2022 A favore
COVID-19: EU coordination of health assessments and risk classification, and the consequences for Schengen and the single market A favore
The cultural recovery of Europe A favore
The draft Commission regulation amending Annexes II, III and IV to Regulation (EC) No 396/2005 as regards maximum residue levels for cycloxydim, flonicamid, haloxyfop, mandestrobin, mepiquat, Metschnikowia fructicola strain NRRL Y-27328 and prohexadione in or on certain products A favore
Measures for a sustainable rail market in view of the COVID-19 pandemic A favore
The humanitarian situation in Mozambique A favore
The case of Dr. Denis Mukwege in the Democratic Republic of the Congo (DRC) A favore
The situation in the Philippines, including the case of Maria Ressa A favore
Resolution on the situation in Russia: the poisoning of Alexei Navalny A favore
The situation in Belarus A favore
The preparation of the special European Council summit focusing on the dangerous escalation and the role of Turkey in the Eastern Mediterranean A favore
Report on the implementation of National Roma Integration Strategies: Combating negative attitudes towards people with Romani background in Europe A favore
Shortage of medicines - how to address an emerging problem A favore
Maximising the energy efficiency potential of the EU building stock A favore
A strategic approach to pharmaceuticals in the environment A favore
Determination of a clear risk of a serious breach by Poland of the rule of law A favore
Annual report on arms export A favore
Just Transition Fund Contro
Real Driving Emissions  (RDE) A favore
Annual implementing report on the EU association agreement with Georgia A favore
Carbon dioxide emissions from maritime transport: global data collection system for ship fuel oil consumption data A favore
Union Civil Protection Mechanism A favore
EU-African security cooperation in the Sahel region, West Africa and the Horn of Africa Contro
The EU’s role in protecting and restoring the world’s forests A favore
The conclusions of the extraordinary European Council meeting of 17-21 July 2020 A favore
Conduct of clinical trials with and supply of medicinal products for human use containing or consisting of genetically modified organisms intended to treat or pent coronavirus disease Astensione
Emission limits and type-approval for internal combustion engines for non-road mobile machinery: transitional provisions in order to address the impact of COVID-19 crisis A favore
The revision of the guidelines for trans-European energy infrastructure A favore
The EU’s public health strategy post-COVID-19 A favore
A comprehensive Union policy on preventing money laundering and terrorist financing – the Commission’s Action Plan and other recent developments A favore
The Chemicals Strategy for Sustainability A favore
European Parliament recommendation to the Council and the Commission concerning the conclusion of an agreement, under negotiation, between the European Union and New Zealand on the exchange of personal data between the European Union Agency for Law Enforcement Cooperation (Europol) and the New Zealand authorities competent for fighting serious crime and terrorism Contro
A comprehensive European approach to energy storage A favore
The draft Commission implementing regulation amending Implementing Regulation (EU) No 540/2011 as regards the extension of the approval periods of the active substances beflubutamid, benalaxyl, benthiavalicarb, bifenazate, boscalid, bromoxynil, captan, cyazofamid, dimethomorph, ethephon, etoxazole, famoxadone, fenamiphos, flumioxazine, fluoxastrobin, folpet, formetanate, metribuzin, milbemectin… A favore
Objection pursuant to Rule 112(2) and (3): Certain uses of chromium trioxide A favore

Righe per pagina: 20 40 100 200 Tutti